Inhibition of ROK exerts a vasodilator effect on pulmonary vasculature [181,282,285] and therapeutic strategies targeting RhoA/ROK signaling is protective against CH-induced PH development in various animal models [282,286,287,288,289]. The gene discussed is RHOA; the disease is cyclic hematopoiesis.